SERPINB5 and breast neoplasm: Contrary to Maass et al (2001a), who failed to detect maspin mRNA in 36% of their breast cancer specimens with a semiquantitative nested RT–PCR assay, we detected maspin mRNA in all the breast tumour samples tested, probably reflecting the higher sensitivity of our real-time RT–PCR method.